TNF-α causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 273, Issue 6 42-6, 1997, Pages

  Worrall, Neil K ^a   Chang, Kathy ^a   LeJeune, Wanda S ^a   Misko, Thomas P ^b   Sullivan, Patrick M ^b   Bruce Ferguson Jr , T ^a   Williamson, Joseph R ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MONSANTO COMPANY   (United States)

^c Box 8118 ^*  (United States)

Author keywords

Blood brain barrier; Capillary permeability; Cytokines; Endothelium; Lung; Nitric oxide

Indexed keywords

AMINOGUANIDINE; CYTOKINE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CAPILLARY PERMEABILITY; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME INHIBITION; GENE EXPRESSION; HYPOTENSION; IMMUNOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG BLOOD VESSEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE INJURY; VASCULAR ENDOTHELIUM;

EID: 0031415919     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.273.6.h2565     Document Type: Article

References (11)

1. Abe, Y., S. Sekiya, T. Yamasita, and F. Sendo. Vascular hyperpermeability induced by tumor necrosis factor and its augmentation by IL-1 and IFN-γ is inhibited by selective depletion of neutrophils with a monoclonal antibody. J. Immunol. 145: 2902-2907, 1990.
2. Bonsignore, M. R., A. Valenti, and M. Spatafora. Tumor necrosis factor-α does not cause lung edema in rabbits. J. Appl. Physiol. 73: 173-178, 1992.
3. Boughton-Smith, N. K., S. M. Evans, F. Laszlo, B. J. R. Whittle, and S. Moncada. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br. J. Pharmacol. 110: 1189-1195, 1990.
4. Brett, J., H. Gerlach, P. Nawroth, S. Steinberg, G. Godman, and D. Stern. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J. Exp. Med. 169: 1977-1991, 1989.
5. Brownlee, M., H. Vlassara, A. Kooney, P. Ulrich, and A. Cerami. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232: 1629-1632, 1986.
6. Chang, S., N. Ohara, G. Kuo, and N. F. Voelkel. Tumor necrosis factor-induced lung injury is not mediated by platelet-activating factor. Am. J. Physiol. 257(Lung Cell. Mol. Physiol. 1): L232-L239, 1989.
7. Cobb, J. P., C. Natanson, Z. M. N. Quezado, W. D. Hoffman, C. A. Koev, S. Banks, R. Correa, R. Levi, R. J. Elin, J. M. Hosseini, and R. L. Danner. Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H1634-H1642, 1995.
8. Edwards, M. J., D. L. Abney, T. Heniford, and F. N. Miller. Passive immunization against tumor necrosis factor inhibits interleukin-2-induced microvascular alterations and reduces toxicity. Surgery 112: 480-486, 1992.
9. Fraker, D. L., H. N. Langstein, and J. A. Norton. Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity. J. Exp. Med. 170: 1015-1020, 1989.
10. Gutierrez, E. G., W. A. Banks, and A. J. Kastin. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 47: 169-176, 1993.
11. Haraldsson, B., L. Regner, R. Hultborn, L. Weiss, and B. Rippe. Transcapillary passage of albumin in mammary tumours and in normal lactating mammary glands of the rat. Acta Physiol. Scand. 122: 497-505, 1984.